SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039808
Filing Date
2023-08-08
Accepted
2023-08-08 16:11:18
Documents
81
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20230630.htm   iXBRL 10-Q 2538499
2 EX-31.1 eftr-ex31_1.htm EX-31.1 20950
3 EX-31.2 eftr-ex31_2.htm EX-31.2 20909
4 EX-32.1 eftr-ex32_1.htm EX-32.1 11718
5 EX-32.2 eftr-ex32_2.htm EX-32.2 11683
  Complete submission text file 0000950170-23-039808.txt   10981550

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20230630_pre.xml EX-101.PRE 527149
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20230630_def.xml EX-101.DEF 381427
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20230630_cal.xml EX-101.CAL 41006
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20230630.xsd EX-101.SCH 88907
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20230630_lab.xml EX-101.LAB 645209
75 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20230630_htm.xml XML 2106398
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 231151412
SIC: 2834 Pharmaceutical Preparations